Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...
5 天
Medpage Today on MSNAtaciguat's Headway in Aortic Stenosis; Baby Pacemakers; AI-ECG Tool for the ED?The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果